“Preeclampsia.com” App To Preeclampsia Screening At Community Level: A Cohort Study

Johariyah Johariyah, Detty Siti Nurdiati, Widyawati Widyawati


Indonesian maternal mortality in 2012, 32.5% was caused by hypertension, preeclampsia, and eclampsia, while 24.22% in 2015 and 26% in 2016. Currently, there is no method of screening for preeclampsia based on maternal characteristics that were carried out during the first visit antenatal. The use of technology has great potential to improve health care at the community, especially in low-middle income countries. It is necessary to make a breakthrough in the form of developing a screening model for preeclampsia by utilizing information technology. This study aims to determine the detection rate of the application of preeclampsia.com as a community-based preeclampsia screening tool. This study was conducted by cohort study  on 549 pregnant women who had their first antenatal visit before 16 weeks followed up to delivery. Data analysis was data of factors for the occurrence of preeclampsia using Chi square, while to determine the strength of the “Preeclampsia.com” model as a screening method and early detection of preeclampsia using multilevel logistic regression,  analysis performed using SPSS version 23.0. The results of the analysis showed that the sensitivity value of the "Preeclampsia.com" application was 64.1% and the specificity value was 85.5% (95% CI). The Positive Predictive Value (PPV) from the "preeclampsia.com" application is 25.3% and the Negative Predictive Value (NPV) from the "preeclampsia.com" application is 96.9%. Based on the results of multilevel logistic regression analysis, it was found that the ability of the model to predict the incidence of preeclampsia was 96.4%. The use of the Preeclampsia.com application is quite good for community-based preeclampsia screening


screening; android app; preeclampsia; community; maternal characteristic

Full Text:



A. P. Mackay, C. J. Berg, and H. K. Atrash, “Pregnancy-related mortality from preeclampsia and eclampsia,” Obstetrics and Gynecology, vol. 97, no. 4, pp. 533–538, 2001, doi: 10.1016/S0029-7844(00)01223-0.

W. J. et al Milne, F. Redman C, “The Pre-Eclampsia Community Guideline (PRECOG): How to Screen for and Detect Onset of Pre-eclampsia in the Community,” Bmj, vol. 330, no. 7491, pp. 576–580, 2005, doi: 10.1136/bmj.330.7491.576.

S. Thangaratinam, J. Allotey, and at al Marlin, “Development and Validation of Prediction Models for Risks of Complications in Early-onset Pre-eclampsia (PREP): A Prospective Cohort Study,” Health Technol Assess (Rockv), vol. 21, no. 18, pp. 1–99, 2017, doi: 10.3310/hta21180.

A. K. Berhe, A. O. Ilesanmi, C. O. Aimakhu, and A. M. Bezabih, “Awareness of pregnancy induced hypertension among pregnant women in Tigray Regional State, Ethiopia,” Pan African Medical Journal, vol. 35, 2020, doi: 10.11604/pamj.2020.35.71.19351.

A. R. Savage and L. Hoho, “Knowledge of pre-eclampsia in women living in Makole Ward, Dodoma, Tanzania,” Afr Health Sci, vol. 16, no. 2, pp. 412–419, Jun. 2016, doi: 10.4314/ahs.v16i2.9.

M. Jabeen, D. Akhter, S. Shimul, and U. Salma, “Health Seeking Behaviour of Women with Eclampsia Attending at Institute of Child and Mother Health in Dhaka City,” vol. 30, no. 02, pp. 67–70, 2018.

D. J. P. Barker, C. Osmond, T. J. Forsen, E. Kajantie, and J. G. Eriksson, “Maternal and Social Origins of Hypertension,” Hypertension, vol. 50, no. 3, pp. 565–571, 2007, doi: 10.1161/HYPERTENSIONAHA.107.091512.

R. Perez-Cuevas et al., “Critical Pathways for the Management of Preeclampsia and Severe Preeclampsia in Institutionalised Health Care Settings,” BMC Pregnancy Childbirth, vol. 3, no. 6, pp. 1–15, 2003, doi: 10.1186/1471-2393-3-6.

L. Verghese, S. Alam, S. Beski, R. Thuraisingham, I. Barnes, and P. MacCallum, “Antenatal Screening for Pre-eclampsia: Evaluation of the NICE and Pre-eclampsia Community Guidelines.,” J Obstet Gynaecol, vol. 32, no. 2, pp. 128–31, 2012, doi: 10.3109/01443615.2011.635224.

Kementrian Kesehatan RI, Buku Kesehatan Ibu dan Anak. 2020.

A. R. Khowaja, C. Mitton, S. Bryan, L. A. Magee, Z. A. Bhutta, and P. von Dadelszen, “Economic Evaluation of Community Level Interventions for Pre-eclampsia (CLIP) in South Asian and African countries: A Study Protocol,” Implementation Science, vol. 10, no. 1, pp. 1–14, 2015, doi: 10.1186/s13012-015-0266-5.

D. T. Dunsmuir et al., “Development of mHealth Applications for Pre-eclampsia Triage,” IEEE J Biomed Health Inform, vol. 18, no. 6, pp. 1857–1864, 2014, doi: 10.1109/JBHI.2014.2301156.

L. F. Garabedian, D. Ross-Degnan, and J. F. Wharam, “Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management,” Curr Diab Rep, vol. 15, no. 12, pp. 1–9, 2015, doi: 10.1007/s11892-015-0680-8.

J. Lim et al., “Usability and Feasibility of PIERS on the Move: An mHealth App for Pre-Eclampsia Triage,” JMIR Mhealth Uhealth, vol. 3, no. 2, p. e37, 2015, doi: 10.2196/mhealth.3942.

E. Ingleby, Research methods in education, vol. 38, no. 3. 2012. doi: 10.1080/19415257.2011.643130.

et al Katherine R, “Development and Validation of a Risk Factor Scoring System for First-Trimester Prediction of Pre-Eclampsia,” NIH Public Acces, vol. 31, no. 12, pp. 1049–1056, 2015, doi: 10.1055/s-0034-1371705.Development.

Z. T. A. Al-Rubaie et al., “Prediction of pre-eclampsia in nulliparous women using routinely collected maternal characteristics: A model development and validation study,” BMC Pregnancy Childbirth, vol. 20, no. 1, pp. 1–14, 2020, doi: 10.1186/s12884-019-2712-x.

B. Mikat, A. Gellhaus, N. Wagner, C. Birdir, R. Kimmig, and A. Köninger, “Early Detection of Maternal Risk for Preeclampsia,” ISRN Obstet Gynecol, vol. 2012, no. July, pp. 1–7, 2012, doi: 10.5402/2012/172808.

P. van Montfort et al., “Implementing a Preeclampsia Prediction Model in Obstetrics: Cutoff Determination and Health Care Professionals’ Adherence,” Medical Decision Making, vol. 40, no. 1, pp. 81–89, 2020, doi: 10.1177/0272989X19889890.

A. K. Akobeng, “Understanding diagnostic tests 1: Sensitivity, specificity and predictive values,” Acta Paediatrica, International Journal of Paediatrics, vol. 96, no. 3, pp. 338–341, 2007, doi: 10.1111/j.1651-2227.2006.00180.x.

J. S. Cnossen et al., “Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal,” Acta Obstet Gynecol Scand, vol. 88, no. 7, pp. 758–765, 2009, doi: 10.1080/00016340903008953.

J. T. Henderson, J. H. Thompson, B. U. Burda, and A. Cantor, “Preeclampsia screening evidence report and systematic review for the US preventive services task force,” JAMA - Journal of the American Medical Association, vol. 317, no. 16, pp. 1668–1683, 2017, doi: 10.1001/jama.2016.18315.

L. McLeod, “How useful is uterine artery Doppler ultrasonography in predicting pre-eclampsia and intrauterine growth restriction?,” Cmaj, vol. 178, no. 6, pp. 727–729, 2008, doi: 10.1503/cmaj.080242.

J. de Freitas Leite, G. A. Rago Lobo, P. M. Nowak, I. R. Antunes, E. Araujo Júnior, and D. B. da Silva Pares, “Prediction of preeclampsia in the first trimester of pregnancy using maternal characteristics, mean arterial pressure, and uterine artery Doppler data in a Brazilian population,” Obstet Gynecol Sci, vol. 62, no. 6, pp. 391–396, 2019, doi: 10.5468/ogs.2019.62.6.391.

M. A. Bujang and T. H. Adnan, “Requirements for minimum sample size for sensitivity and specificity analysis,” Journal of Clinical and Diagnostic Research, vol. 10, no. 10, pp. YE01–YE06, 2016, doi: 10.7860/JCDR/2016/18129.8744.

N. Prakansamut and V. Phupong, “Serum SHARP1 and uterine artery Doppler for the prediction of preeclampsia,” Sci Rep, vol. 9, no. 1, pp. 1–7, 2019, doi: 10.1038/s41598-019-48727-8.

Z. Al-Rubaie, L. Askie, J. Ray, H. Hudson, and S. Lord, “The Performance of Risk Prediction Models for Pre-eclampsia Using Routinely Collected Maternal Characteristics and Comparison With Models that Include Specialised Tests and With Clinical Guideline Decision Rules: a Systematic Review,” BJOG, vol. 123, no. 9, pp. 1441–1452, 2016, doi: 10.1111/1471-0528.14029.

C. Montagnoli and G. Larciprete, “Preeclampsia: Definitions, Screening Tools and Diagnostic Criteria in Supersonic Era,” World J Obstet Gynecol, vol. 3, no. 3, pp. 98–109, 2014, doi: 10.5317/wjog.v3.i3.98.

W. N. Costa Fabrício da Silva, Murth Padma, Keog Rosemary, “Early Screening for Preeclampsia,” Ravista Brasiliiera de Ginecologia e Obstetricia, vol. 33, no. 11, pp. 357–75, 2011.

Y. Yu et al., “The Combined Association of Psychosocial Stress and Chronic Hypertension with Preeclampsia,” vol. 209, no. 5, pp. 1–16, 2014, doi: 10.1016/j.ajog.2013.07.003.The.

A. T. dan N. L. Ririn A, “The Relationship of Antenatal Care (ANC) Visits with the Incidence of Preeclampsia in Pregnant WOmen at Gynegology Polyclicic of Immanuel Hospital Bandung,” in International Nursing Workshop and Conference, 2016, pp. 250–250. doi: 10.4234/jjoffamilysociology.28.250.

DOI: https://doi.org/10.31983/jkb.v13i1.9484

Article Metrics

Abstract view : 266
Download PDF : 340


  • There are currently no refbacks.

Abstracted/Indexed by:

Creative Commons License

Jurnal Kebidanan by http://ejournal.poltekkes-smg.ac.id/ojs/index.php/jurkeb is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

View My Stats